Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Company

Micro Labs

Pharmaceutical intelligence for Micro Labs with 36 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
20
Catalysts
16
Assets
15

Recent signals(20)

RegulatoryAugust 6, 2026

FDA Approval Process for Brimonidine Tartrate by Micro Labs

The FDA has accepted the application ANDA218558 for Brimonidine Tartrate submitted by Micro Labs.

RegulatoryAugust 3, 2026

FDA Approves Torsemide Application ANDA217239 from Micro Labs

The FDA has approved the ANDA217239 application for Torsemide submitted by Micro Labs.

RegulatoryJuly 30, 2026

FDA Approves Ticagrelor Application ANDA208539 by Micro Labs

The FDA has approved the original application for Ticagrelor (ANDA208539) submitted by Micro Labs.

Strategy
July 28, 2026

FDA Approves Escitalopram Oxalate Application by Micro Labs

The FDA has approved the ANDA091655 application for Escitalopram Oxalate submitted by Micro Labs.

RegulatoryJuly 26, 2026

FDA Grants AP Status for Ramelteon ANDA 215243 by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Ramelteon submitted by Micro Labs.

RegulatoryJuly 26, 2026

FDA Approval Process for Olmesartan Medoxomil and Hydrochlorothiazide by Micro Labs

The FDA has received an application for Olmesartan Medoxomil and Hydrochlorothiazide from Micro Labs, currently under standard review.

RegulatoryJuly 22, 2026

FDA Approval Letter for Tofacitinib Citrate by Micro Labs

The FDA has issued an approval letter for ANDA209738 for Tofacitinib Citrate submitted by Micro Labs.

StrategyJuly 19, 2026

FDA Grants Approval for Mirtazapine ANDA220104 by Micro Labs

The FDA has granted approval for the ANDA220104 application for Mirtazapine submitted by Micro Labs.

RegulatoryJuly 18, 2026

FDA Grants Approval for Micro Labs' Choline Fenofibrate ANDA213450

The FDA has granted approval for Micro Labs' Abbreviated New Drug Application (ANDA) for Choline Fenofibrate.

RegulatoryJuly 13, 2026

FDA Grants Approval for Brimonidine Tartrate ANDA218558 by Micro Labs

The FDA has granted approval for the ANDA218558 application for Brimonidine Tartrate submitted by Micro Labs.

RegulatoryJuly 12, 2026

FDA Grants Approval for Torsemide ANDA217239 by Micro Labs

The FDA has granted approval for the ANDA217239 application for Torsemide submitted by Micro Labs.

RegulatoryJuly 9, 2026

FDA Approval Status for Tranexamic Acid by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Tranexamic Acid submitted by Micro Labs.

StrategyJuly 9, 2026

FDA Grants Approval for Rivaroxaban Generic by Micro Labs

The FDA has granted approval for the generic version of Rivaroxaban submitted by Micro Labs.

RegulatoryJuly 8, 2026

FDA Grants Approval for Prucalopride Succinate by Micro Labs

The FDA has granted approval for Prucalopride Succinate under application ANDA219180 submitted by Micro Labs.

StrategyJuly 5, 2026

FDA Approves ANDA for Escitalopram Oxalate by Micro Labs

The FDA has granted approval for ANDA091655, a generic version of Escitalopram Oxalate submitted by Micro Labs.

RegulatoryJuly 3, 2026

FDA Accepts Supplement Application for Ramelteon by Micro Labs

The FDA has accepted a supplemental application for Ramelteon submitted by Micro Labs.

StrategyJune 30, 2026

FDA Grants Approval for Propranolol Hydrochloride ANDA217238

The FDA has granted approval for the ANDA217238 application for Propranolol Hydrochloride submitted by Micro Labs.

RegulatoryJune 27, 2026

FDA Approves ANDA220768 for Fluvoxamine Maleate by Micro Labs

The FDA has approved the Abbreviated New Drug Application (ANDA220768) for Fluvoxamine Maleate submitted by Micro Labs.

StrategyJune 9, 2026

FDA Grants Approval for Olmesartan Medoxomil and Hydrochlorothiazide ANDA206371

The FDA has granted approval for ANDA206371, a combination of Olmesartan Medoxomil and Hydrochlorothiazide, submitted by Micro Labs.

RegulatoryJune 7, 2026

FDA Approval Status Update for Losartan Potassium by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Losartan Potassium submitted by Micro Labs.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity(14)

RegulatoryAugust 6, 2026

FDA Approval Process for Brimonidine Tartrate by Micro Labs

The FDA has accepted the application ANDA218558 for Brimonidine Tartrate submitted by Micro Labs.

RegulatoryAugust 3, 2026

FDA Approves Torsemide Application ANDA217239 from Micro Labs

The FDA has approved the ANDA217239 application for Torsemide submitted by Micro Labs.

RegulatoryJuly 30, 2026

FDA Approves Ticagrelor Application ANDA208539 by Micro Labs

The FDA has approved the original application for Ticagrelor (ANDA208539) submitted by Micro Labs.

RegulatoryJuly 26, 2026

FDA Grants AP Status for Ramelteon ANDA 215243 by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Ramelteon submitted by Micro Labs.

RegulatoryJuly 26, 2026

FDA Approval Process for Olmesartan Medoxomil and Hydrochlorothiazide by Micro Labs

The FDA has received an application for Olmesartan Medoxomil and Hydrochlorothiazide from Micro Labs, currently under standard review.

RegulatoryJuly 22, 2026

FDA Approval Letter for Tofacitinib Citrate by Micro Labs

The FDA has issued an approval letter for ANDA209738 for Tofacitinib Citrate submitted by Micro Labs.

RegulatoryJuly 18, 2026

FDA Grants Approval for Micro Labs' Choline Fenofibrate ANDA213450

The FDA has granted approval for Micro Labs' Abbreviated New Drug Application (ANDA) for Choline Fenofibrate.

RegulatoryJuly 13, 2026

FDA Grants Approval for Brimonidine Tartrate ANDA218558 by Micro Labs

The FDA has granted approval for the ANDA218558 application for Brimonidine Tartrate submitted by Micro Labs.

RegulatoryJuly 12, 2026

FDA Grants Approval for Torsemide ANDA217239 by Micro Labs

The FDA has granted approval for the ANDA217239 application for Torsemide submitted by Micro Labs.

RegulatoryJuly 9, 2026

FDA Approval Status for Tranexamic Acid by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Tranexamic Acid submitted by Micro Labs.

RegulatoryJuly 8, 2026

FDA Grants Approval for Prucalopride Succinate by Micro Labs

The FDA has granted approval for Prucalopride Succinate under application ANDA219180 submitted by Micro Labs.

RegulatoryJuly 3, 2026

FDA Accepts Supplement Application for Ramelteon by Micro Labs

The FDA has accepted a supplemental application for Ramelteon submitted by Micro Labs.

RegulatoryJune 27, 2026

FDA Approves ANDA220768 for Fluvoxamine Maleate by Micro Labs

The FDA has approved the Abbreviated New Drug Application (ANDA220768) for Fluvoxamine Maleate submitted by Micro Labs.

RegulatoryJune 7, 2026

FDA Approval Status Update for Losartan Potassium by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Losartan Potassium submitted by Micro Labs.

Clinical activity

No signals indexed for this entity yet.

Competitive activity

No signals indexed for this entity yet.

Assets

Brimonidine Tartrate →
Escitalopram →
Ezetimibe →
FDA →
Fluvoxamine Maleate →
Hydrochlorothiazide →
Losartan Potassium →
Mirtazapine →
Nephron →
Propranolol Hydrochloride →
Prucalopride Succinate →
Ramelteon →
Regulatory Approval →
Ticagrelor →
Torsemide →

Therapeutic areas

Anticoagulant →
Antidepressant →
Antifibrinolytic →
Antihypertensive →
Antiplatelet →
Beta-blocker →
Cardiology →
Cardiology · Beta-blocker →
Cardiovascular →
Cardiovascular · Anticoagulant →
Cardiovascular · Antihypertensive →
Cardiovascular · Beta-blocker →
Cardiovascular · Diuretic →
Cardiovascular · Hypercholesterolemia →
Cardiovascular · Hypertension →
Cardiovascular · Lipid Regulation →
Cardiovascular · Vasopressor →
Constipation →
Diuretic →
Gastroenterology →
Gastroenterology · Constipation →
Glaucoma →
Hematology →
Hematology · Antifibrinolytic →
Hypertension →
Immunology →
JAK Inhibitor →
Lipid Regulation →
Melatonin Receptor Agonist →
Ophthalmology →
Ophthalmology · Glaucoma →
Psychiatry →
Psychiatry · Antidepressant →
Psychiatry · SSRI →
Sleep Disorders →
Sleep Disorders · Melatonin Receptor Agonist →
SSRI →

Indications

Sleep Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.